Skip to main content

Table 3 Multivariate Cox regression analysis in patients with ESCC

From: Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy

Parameters

OS

PFS

 

HR

95% CI

p value

HR

95% CI

p value

Tumor location

  

0.949

  

0.474

 Upper

1

  

1

  

 Middle

1.091

0.585–2.036

0.784

1.014

0.545–1.885

0.965

 Lower

1.133

0.496–2.588

0.767

1.501

0.691–3.258

0.305

Clinical T stage

     

0.183

 T1

–

–

 

1

  

 T2

–

–

 

0.739

0.281–1.943

0.540

 T3

–

–

 

1.492

0.543–4.103

0.438

 T4

–

–

 

0.794

0.248–2.539

0.697

SUVTumor

1.040

0.993–1.089

0.098

1.049

0.999–1.102

0.054

MTV (cm3)

1.018

1.006–1.031

0.005

1.019

1.005–1.034

0.009

PLNS number

1.013

0.940–1.091

0.738

–

–

 

SDmax(LN-T)

6.988

2.119–23.042

0.001

5.819

1.921–17.628

0.002

  1. OS, overall survival; PFS, progression-free survival; HR, hazard ratio; CI, confidence interval; SUVTumor, SUVmax of primary tumor; MTV, metabolic tumor volume; PLNS, PET positive lymph nodes; SDmax(LN-T), the shortest distance between the farthest PET positive lymph node and the primary tumor in three-dimensional space after the standardization of the patient BSA
  2. Values in bold indicate a significant result (p < 0.05)